Brainsway Reports Positive Final Results of Study Using Deep TMS to Treat OCD

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

JERUSALEM, Sept. 4, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to report the final results of a clinical trial conducted at the Sheba Medical Center at Tel Hashomer to assess the efficacy of the Company's Deep TMS device in treating obsessive-compulsive disorder ("OCD") using a specialized coil developed for this purpose.

Help employers find you! Check out all the jobs and post your resume.

Back to news